Key result
Recent clinical trials indicate that lowering blood pressure, rather than the specific medication chosen, accounts for most cardiovascular benefits, though ACE inhibitors and low-dose combinations are recommended as initial therapy.
Why the study?
How do recent clinical trial results impact national recommendations for the pharmacological management of hypertension?
Population
Hypertensive patients, including young, elderly, diabetics, and high-risk individuals
Comparison
Antihypertensive therapy including ACE… vs Alternative antihypertensive regimens or older…
Design
Review
Authors
Loading...
Supports BP lowering as primary goal in hypertension; extends trial evidence by reinforcing ACE inhibitors and combinations in national guidelines.
How do recent clinical trial results impact national recommendations for the pharmacological management of hypertension?
Recent clinical trials support the use of ACE inhibitors, ARBs, diuretics, and beta blockers as initial therapy for hypertension, emphasizing the need for combination therapy to reach blood pressure goals.
Marvin Moser (2002) conducted a review in Hypertension. Antihypertensive therapy (various classes) vs. Placebo or alternative antihypertensive classes was evaluated. Recent clinical trials indicate that lowering blood pressure, rather than the specific medication chosen, accounts for most cardiovascular benefits, though ACE inhibitors and low-dose combinations are recommended as initial therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: